Yilin Yu

school of medicine

H指数:15

被引数:1,017

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a risk-stratified follow-up strategy based on early and late recurrence risk factors in locally advanced esophageal squamous cell carcinoma after definitive chemoradiotherapy

基于早期和晚期复发风险因素制定局部晚期食管鳞状细胞癌根治性化放疗后风险分层随访策略

Frontiers in Oncology

IF3.3

2026-09-240

OAAI

Integrated absolute-quantitative gut microbiota profiling and targeted metabolomics reveal microbial and metabolic alterations in children with juvenile idiopathic arthritis

整合绝对定量肠道菌群分析与靶向代谢组学揭示幼年特发性关节炎患儿肠道菌群和代谢物的改变

BMC Microbiology

IF4.2

2026-09-030

SHC Adaptor Protein 1 Drives Cancer-Associated Fibroblast-Mediated Immune Exclusion and Notch-Dependent Angiogenesis

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2026-01-010

PRE

HERV6196 as an enhancer with oncogenic potential in rectal cancer

HERV6196 作为一种具有致癌潜能的增强子在直肠癌中的作用

MICROBIOLOGY SPECTRUM

IF3.8

2025-12-010

PRE

Hedgehog signaling pathway is an influential factor on vascular biology: a review

Hedgehog信号通路是血管生物学的重要影响因素：一篇综述

Journal of Physiology and Biochemistry

IF4.3

2025-08-020

OAAI

Potential Role of PARVB in Macrophage-Mediated Immunosuppression and Cervical Cancer Progression

PARVB在巨噬细胞介导的免疫抑制和宫颈癌进展中的潜在作用

Laboratory Investigation

IF4.2

2025-07-290

PRE

Investigating the Impact of B Cell-Related Genes on Colorectal Cancer Immunosuppressive Environment and Immunotherapy Evasion

DRUG DEVELOPMENT RESEARCH

IF4.2

2025-01-270

PRE

Unveiling Immunotherapy Evasion in Lung Cancer: The Role of Fanconi Anemia and Stemness Genes in Shaping an Immunosuppressive Microenvironment

DRUG DEVELOPMENT RESEARCH

IF4.2

2024-11-210

PRE

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-10-170

OAAI

Comprehensive analysis of the prognostic value of pre-treatment nutritional indicators in elderly rectal cancer patients

SCIENTIFIC REPORTS

IF3.9

2024-09-271

OAAI

Glutaminolysis provides nucleotides and amino acids to regulate osteoclast differentiation in mice

EMBO REPORTS

IF6.2

2024-09-131

Prognostic and immunological implications of glutathione metabolism genes in lung adenocarcinoma: A focus on the core gene SMS and its impact on M2 macrophage polarization

肺腺癌谷胱甘肽代谢基因的预后和免疫学意义: 核心基因SMS及其对M2巨噬细胞极化的影响

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-05-012

PRE

Mitochondrial ribosomal protein S24 is associated with immunosuppressive microenvironment and cold tumor in lung adenocarcinoma

线粒体核糖体蛋白S24与肺腺癌的免疫抑制微环境和冷肿瘤有关

HELIYON

IF3.6

2024-04-010

OAAI

Prognostic and immunological role of cancer-associated fibroblasts-derived exosomal protein in esophageal squamous cell carcinoma

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-11-016

PRE

Glutathione limits RUNX2 oxidation and degradation to regulate bone formation

JCI INSIGHT

IF6.1

2023-08-2220

Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy

BMC CANCER

IF3.4

2023-06-288

OAAI

Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-05-083

OAAI

Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma

THORACIC CANCER

IF2.3

2023-02-242

OAAI

Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy

FRONTIERS IN ONCOLOGY

IF3.3

2022-11-224

OAAI

SLC38A2 provides proline and alanine to regulate postnatal bone mass accrual in mice

FRONTIERS IN PHYSIOLOGY

IF3.4

2022-09-2312

OAAI

Yilin Yu

个人简介

教育背景

工作经历

荣誉奖项

研究方向